Ignite Creation Date:
2025-12-24 @ 3:02 PM
Ignite Modification Date:
2026-07-02 @ 7:00 PM
Study NCT ID:
NCT04475159
Status:
UNKNOWN
Last Update Posted:
2020-07-17
First Post:
2020-07-14
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Combined Neoadjuvant Systemic and PIPAC Therapy (NASPIT) for Patients With Colorectal Peritoneal Metastasis Eligible for CRS and HIPEC: A Prospective Phase II Trial
Sponsor:
Prof. Aviram Nissan
Organization:
Organization Data
Organization:
Class:
OTHER_GOV
Study ID:
6881-20-SMC
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER_GOV
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None